CBD

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

A 2018 study showed that, for patients with schizophrenia, adding CBD to ongoing antipsychotic treatment reduced psychotic activity, as compared to placebo add-on

View this review (yellow link) or download:

This paper is also stored here: http://bit.ly/2WztI04    inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDCannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
read more

CBD reduces seizures and social deficits in a mouse model of Dravet syndrome

CBD treatment in a mouse model for Dravet Syndrome effectively reduced seizures and autism-like behaviors

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WA1jXO     inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDCBD reduces seizures and social deficits in a mouse model of Dravet syndrome
read more

Cannabidiol in Anxiety and Sleep: A Large Case Series

In a study of 72 psychiatric patients given CBD in capsule form, researchers found that cannabidiol successfully decreased anxiety and improved sleep over the course of three months. 

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WDo4yV     inside the CED Foundation Archive

To explore related information, click keywords:

Benjamin Caplan, MDCannabidiol in Anxiety and Sleep: A Large Case Series
read more

The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?

Animal models show that cannabis has anti-compulsive effects, and OCD patients say that cannabis improves their symptoms. Now scientists are asking for more research.

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WABCpO     inside the CED Foundation Archive

To explore related information, click keywords:

Benjamin Caplan, MDThe Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?
read more

Influence of the CB1 cannabinoid receptors & antidepressant effects

Study finds that, for patients already taking antidepressants, activating and/or prohibiting the CB1 receptor in the brain might make those antidepressants more effective.

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/31ngEPb      inside the CED Foundation Archive

To explore related information, click keywords:

Benjamin Caplan, MDInfluence of the CB1 cannabinoid receptors & antidepressant effects
read more

Video: Cannabis For Symptoms of chronic pain, seizures, and inflammation

View this review (yellow link) or download:

This paper is also stored here:   http://bit.ly/2l4sexZ      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDVideo: Cannabis For Symptoms of chronic pain, seizures, and inflammation
read more

Medical Marijuana Confers Benefits Comparable to Prescription Medication, Without the Side Effects

Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses

In a survey of 30 patients using medical cannabis for a range of illnesses, including Rheumatoid Arthritis, cancer, Hepatitis C, PTSD, and more, patients reported an array of benefits from their cannabis use. Patients successfully used cannabis as an alternative to prescription medication, as a complementary agent with traditional prescription medicines, and to gradually help halt the use of some prescription medications. Benefits described by participants included the effects of cannabis lasting longer than that of opioids, lower risk of addiction, fewer side-effects. Patients also saw their sleep, anxiety, appetite, and adverse reactions improve with the use of medical cannabis. Larger, more controlled studies may suggest cannabis more affirmatively as an alternative or complementary therapy with prescription medications.

View this review (yellow link) or download:


This paper is also stored here:   http://bit.ly/2wqDDdQ      inside the CED Foundation Archive


To explore related information, click keywords:

Benjamin Caplan, MDMedical Marijuana Confers Benefits Comparable to Prescription Medication, Without the Side Effects
read more

Some, But Not Enough Data on Cannabis for Chronic Pain

Overlaps in pharmacology for the treatment of chronic pain and mental health disorders

Select small trials have demonstrated cannabis to be more effective than other analgesics to treat chronic pain associated with certain conditions. However, the existing research lacks large-scale, controlled experiments relating medical cannabis use to pain management. Additionally, negative effects are documented with respect to cannabis use among adolescents and those suffering from compromised mental health. There is a need for further research on the topic.

View this review (yellow link) or download:

This paper is also stored here: http://bit.ly/2wtvpRY inside the CED Foundation Archive

To explore related information, click keywords:

Benjamin Caplan, MDSome, But Not Enough Data on Cannabis for Chronic Pain
read more

Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

Because of the associated anti-inflammatory action, modulation of CB1R & CB2R is helpful to treat autoimmune diseases, including Multiple Sclerosis, Type-1 Diabetes Mellitus, and Rheumatoid Arthritis The full list is truly very much longer, as every illness necessarily involves the immune system and cellular communication.

The following review, written by Elaine D. Gonc ̧alves

The following review, written by Daphna Katz-Talmor: (yes, same name, unfortunately!)

Benjamin Caplan, MDCannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?
read more